AI Article Synopsis

  • Macrocyclization improves the effectiveness of peptides as therapeutics, addressing their limitations.
  • A new amino acid, p-chloropropynyl phenylalanine (pCPF), enables spontaneous macrocyclization of peptides during in vitro translation when combined with cysteine.
  • This method allows for various ring sizes and the testing of different non-canonical amino acids (ncAAs), paving the way for innovative macrocyclic peptide libraries and enhanced translation studies.

Article Abstract

Macrocyclization has proven to be a beneficial strategy to improve upon some of the disadvantages of peptides as therapeutics. Nevertheless, many peptide cyclization strategies are not compatible with in vitro display technologies like mRNA display. Here we describe the novel amino acid p-chloropropynyl phenylalanine (pCPF). pCPF is a substrate for a mutant phenylalanyl-tRNA synthetase and its introduction into peptides via in vitro translation leads to spontaneous peptide macrocyclization in the presence of peptides containing cysteine. Macrocyclization occurs efficiently with a wide variety of ring sizes. Moreover, pCPF can be reacted with thiols after charging onto tRNA, enabling the testing of diverse ncAAs in translation. The versatility of pCPF should facilitate downstream studies of translation and enable the creation of novel macrocyclic peptide libraries.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11165969PMC
http://dx.doi.org/10.1002/cbic.202300020DOI Listing

Publication Analysis

Top Keywords

p-chloropropynyl phenylalanine
8
amino acid
8
peptide macrocyclization
8
phenylalanine versatile
4
versatile non-canonical
4
non-canonical amino
4
acid co-translational
4
peptide
4
co-translational peptide
4
macrocyclization
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!